Pancreatic cancer, often dubbed the “King of Cancers” due to its aggressive nature and poor prognosis, remains a critical health concern in Hong Kong, ranking as the fifth leading cause of cancer-related mortality. In 2019 alone, the Hong Kong Cancer Registry recorded 946 new cases, with a male-to-female ratio of approximately 1.3 to 1 (530 male cases against 416 female cases), according to data from the Hospital Authority. The disease’s deep abdominal location and a notable absence of early symptoms significantly hamper detection, often leading to diagnosis only at advanced stages, underscoring the urgent need for enhanced public awareness and early screening strategies.
Misleading Symptoms Mask Hidden Danger
The insidious nature of pancreatic cancer was highlighted in a recent case shared by Taiwanese gastroenterologist Dr. Lin Hsiang-hung, involving a 60-year-old male patient with seemingly healthy lifestyle habits. Despite being a non-smoker and non-drinker who reported no physical discomfort, the man had recently experienced a 4kg loss of weight, which he mistakenly attributed to successful dietary control. Although his blood sugar levels were elevated, indicating pre-diabetes, the lack of traditional symptoms provided a false sense of security.
However, a routine health check blood test revealed alarmingly high levels of the tumor marker CA 19-9, measuring 800 U/mL—20 times the normal limit. Subsequent CT scans identified a 2.5 cm tumor in the pancreas, suggesting a high probability of malignancy. Confronted with the unexpected diagnosis, and because he felt well, the patient initially refused surgical intervention, opting for continued observation instead.
Rapid Progression Underscores Treatment Urgency
This decision to “wait and see” proved gravely detrimental. Just three months later, a follow-up scan showed dramatic tumor growth, increasing its size by 44 percent, from 2.5 cm to 3.6 cm. Dr. Lin strongly advised immediate surgery, emphasizing that the window for effective treatment was rapidly closing.
This case exemplifies a critical pattern in pancreatic cancer: the belief that small tumors or the absence of symptoms permit delay. Dr. Lin stresses that 70 percent of early pancreatic cancer cases are asymptomatic, with over half of these being discovered incidentally during examinations for unrelated conditions. Furthermore, research indicates that pancreatic cancer can metastasize even when the tumor is small.
Early detection correlates directly with markedly improved outcomes:
- Surgery for tumors under 2 cm has an approximate five-year survival rate of 50%.
- This survival rate drastically drops to only 15% for tumors ranging from 2 cm to 4 cm.
Recognizing Subtle Metabolic Shifts
Since early symptoms are rare, medical professionals urge individuals to pay close attention to subtle metabolic changes. Dr. Lin notes that up to 80 percent of pancreatic cancer patients exhibit high blood sugar levels. Consequently, any unexplained rise in blood glucose coupled with significant, involuntary weight loss should not be dismissed as a positive result of dieting but investigated immediately as a potential malignancy indicator.
While genetic factors play a role, lifestyle choices and dietary habits also influence risk. Given the high mortality rate—often cited as having a nine-in-ten chance of death within the first year of diagnosis—proactive screening and immediate response to suspicious indicators are paramount to improving outcomes against this aggressive disease. Healthcare providers continue to highlight that in the fight against this silent killer, the absence of pain does not equate to the absence of disease.